about
Engineered Viruses as Genome Editing DevicesGene therapy for hemophiliaDeregulated Nras expression in knock-in animals harboring a gammaretroviral long terminal repeat at the Nras/Csde1 locus.Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.Molecular mechanisms of retroviral integration site selection.Cell replacement therapies: is it time to reprogram?Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells.Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy.Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systemsHigh-throughput monitoring of integration site clonality in preclinical and clinical gene therapy studies.Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.Characterization of Equine Infectious Anemia Virus Integration in the Horse GenomeEfficient production of superior dumbbell-shaped DNA minimal vectors for small hairpin RNA expression.Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.Inhibition of Sox2 Expression in the Adult Neural Stem Cell Niche In Vivo by Monocationic-based siRNA DeliveryBET proteins promote efficient murine leukemia virus integration at transcription start sites.Nanoparticle-mediated conversion of primary human astrocytes into neurons and oligodendrocytesRetrovirus Integration Database (RID): a public database for retroviral insertion sites into host genomesIn Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution PhasesTherapeutic margins in a novel preclinical model of retinitis pigmentosa.Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.Development of gene therapy for thalassemia.Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies.Adoptive immunotherapy for cancer or viruses.Lentiviral vectors for the treatment of primary immunodeficiencies.Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.CRISPR genome engineering and viral gene delivery: a case of mutual attraction.The FACT Complex Promotes Avian Leukosis Virus DNA Integration.Advanced Design of Dumbbell-shaped Genetic Minimal Vectors Improves Non-coding and Coding RNA Expression.Management of knee osteoarthritis. Current status and future trends.Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions.Integration site selection by retroviruses and transposable elements in eukaryotes.Adenoviral vector DNA for accurate genome editing with engineered nucleases.Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.
P2860
Q26785927-C89C7C6C-3FC3-4C7F-81CD-EED232DC219AQ28081911-6BA2C3CC-7210-4DDB-8D82-482580BE019FQ31111203-FABE6481-E98F-46BC-B921-50851CE4DA33Q33903286-963FE43A-DAE1-44BF-91C1-09EC391289ECQ34249653-EFB04045-D3A2-4133-8615-7ADE0B58E6CFQ34267315-EA499AB6-80A6-47D9-AEB2-18E06514D3FDQ34323979-6610EB78-ECFB-4DB3-BDFA-D7B9B55C6AECQ34356904-8ECCF453-65B9-4DE9-B587-825DC84DEF2BQ34484917-F5C22837-86EB-47CD-9786-F16A135AE6FFQ35110771-035586B0-6A19-4BE5-8311-FE324CCCD868Q35665038-7C8A9CFF-A923-49C9-8AAA-DF770BE6A3F8Q35711209-DEC8834D-C870-47BD-8584-2517F94037D5Q35808693-B1CC27C7-554C-4EA9-9AFF-AD4726328199Q36160587-0C7F6028-A2C2-40E0-8507-2C860323F469Q36469473-FCA1182D-2CE6-4203-BE8D-5EA807009195Q36532676-21CA6449-B531-4F8B-A89B-0C40264196EDQ36698269-7E3518FE-EDE1-4EB2-87E2-5773E9BF038CQ36832232-E3A46433-2972-4D38-B0ED-22F5BD510DAFQ37031911-1BAEC464-E4B3-4CBD-AAFD-7ADA0F51B8B5Q37041873-4B6E3E82-4AFA-4FAD-8180-6A812319667FQ37064393-D5D3DDB2-D440-44B0-BAFD-4C04D572AB27Q37089345-8B631E20-1D56-4185-A042-F906886A7269Q37093907-5F0D0432-DA11-4D7A-ADEF-21C14C321E54Q37406920-53891368-83B3-4075-872A-284EB6E13DA9Q37734367-C6A988C4-66C4-42AD-9A9D-D871D21D3C0FQ38057725-840CBED9-BC46-4DD4-8EDC-2993FEA6121BQ38079633-BC4B6815-A8D9-47AF-AF4F-84BDF718CF85Q38178359-22103555-0B1C-45B5-8DCF-1EA135D925FBQ38195200-60EAC369-25E9-400C-8747-6B9923AA0782Q38321965-E3CAEF7E-CFF6-4E00-A907-82FE6D1BC92DQ38348602-D270EC50-2C42-4F49-A580-901975361F67Q38719417-8C8DDB60-971E-4081-85D7-1A3761532B97Q38760825-399CC422-ED3B-47D9-B57C-5E46FB4C626FQ38822218-89FEED02-7D04-4B6D-A31B-089A284B6DEEQ38874124-4CF56626-12CB-40A2-A1FA-52605AE34DFBQ38874946-2A98DFC5-CFF8-4210-93FE-028F7D27A841Q38912198-3D12B9AD-300D-4261-90C4-F7D4869AC90DQ38963280-F953880D-5749-4E75-B8D4-2E94E03516FCQ38999828-971EE001-4889-4B26-A1EE-48ED18DC32B7Q39042768-18DB0736-4FAE-4D78-8505-1098CD337CC4
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Retroviral integrations in gene therapy trials
@ast
Retroviral integrations in gene therapy trials
@en
Retroviral integrations in gene therapy trials
@nl
type
label
Retroviral integrations in gene therapy trials
@ast
Retroviral integrations in gene therapy trials
@en
Retroviral integrations in gene therapy trials
@nl
prefLabel
Retroviral integrations in gene therapy trials
@ast
Retroviral integrations in gene therapy trials
@en
Retroviral integrations in gene therapy trials
@nl
P2860
P921
P3181
P356
P1433
P1476
Retroviral integrations in gene therapy trials
@en
P2093
Cristina Baricordi
Luca Biasco
P2860
P304
P3181
P356
10.1038/MT.2011.289
P407
P577
2012-01-17T00:00:00Z